Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Enbrel (etanercept) and Humira (adalimumab) are both biologic DMARDs used to treat autoimmune conditions, but they have some differences. Enbrel and Humira are both available as brand-name products and also have several biosimilars. Enbrel is typically injected once a week, whereas Humira is usually given every other week. Humira treats a broader range of conditions, including Crohn's disease, ulcerative colitis, hidradenitis suppurativa, and uveitis, which Enbrel does not. Both medications can raise the risk of serious infections and certain cancers, but they have different dosing schedules and specific side effects. Enbrel is known for causing injection site reactions and common colds, while Humira can cause headaches and sinus infections.
Enbrel (etanercept)
Humira (adalimumab)
Enbrel (etanercept)
Humira (adalimumab)
Summary of Enbrel vs. Humira
Summary for Biologic DMARD
Prescription only
Enbrel (etanercept) is a weekly injection used for many autoimmune conditions. Currently, it's only available as a brand-name product and can be expensive.
Summary for Biologic DMARD
Prescription only
Humira (adalimumab) is an injectable medication used for treating many different autoimmune conditions, including rheumatoid arthritis (RA), Crohn's disease (CD), ulcerative colitis (UC), and plaque psoriasis. It's usually given every other week, and it can be used alone or taken with methotrexate or other non-biologic medications. This medication is available as many different brands (or biosimilars).
Indications of Enbrel vs. Humira
Indications for
•Rheumatoid arthritis (RA)
•Plaque psoriasis (PsO) and psoriatic arthritis (PsA)